Baseline | Week 12 | Difference between before and after treatment | SES | SRM | ||||
---|---|---|---|---|---|---|---|---|
x - ± SD | x - ± SD | x - ± SD | P | T | 95% CI | |||
Primary bothersome symptom | 6.96 ± 2.22 | 3.89 ± 2.50 | 3.06 ± 2.86 | <0.001 | 14.68 | 2.65 - 3.48 | 1.38 | 1.07 |
Secondary bothersome symptom | 6.37 ± 2.34 | 3.50 ± 2.45 | 2.87 ± 2.88 | <0.001 | 13.67 | 2.46 - 3.29 | 1.23 | 1.00 |
ZRADSQ | 15.14 ± 6.74 | 8.78 ± 5.62 | 6.35 ± 6.29 | <0.001 | 13.84 | 5.45 - 7.26 | 0.94 | 1.01 |
SCORAD | 47.61 ± 15.57 | 26.85 ± 15.56 | 20.76 ± 15.34 | <0.001 | 18.56 | 18.55 - 22.97 | 1.33 | 1.35 |